TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger January 10, 1997
TCL Archive As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move September 13, 2002
